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In vitro human pluripotent stem cell (hPSC) derived tissues are excellent models to study certain aspects
of normal human development. Current research in the ﬁeld of hPSC derived tissues reveals these
models to be inherently fetal-like on both a morphological and gene expression level. In this review we
brieﬂy discuss current methods for differentiating lung and intestinal tissue from hPSCs into individual
3-dimensional units called organoids. We discuss how these methods mirror what is known about in vivo
signaling pathways of the developing embryo. Additionally, we will review how the inherent immaturity
of these models lends them to be particularly valuable in the study of immature human tissues in the
clinical setting of premature birth. Human lung organoids (HLOs) and human intestinal organoids (HIOs)
not only model normal development, but can also be utilized to study several important diseases of
prematurity such as respiratory distress syndrome (RDS), bronchopulmonary dysplasia (BPD), and ne-
crotizing enterocolitis (NEC).
& 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Background
The gastrointestinal and respiratory systems are intricate,
complex, and critical organ structures. Development of both
structures begins following the establishment of the primary germ
layers during gastrulation. As embryogenesis progresses, the en-
doderm will undergo complex gut-tube morphogenesis, resulting
in epithelium lining the primitive gut tube with the mesoderm
contributing to the majority of the supporting structures around it
(Sinagoga and Wells, 2015; Wells and Spence, 2014). The gut tube
is functionally and geographically divided into three regions along
the rostral-caudal axis: the foregut, the midgut and the hindgut
(Grapin-Botton, 2005; Zorn and Wells, 2009). Historically, these
regions have been distinguished anatomically based on vascular-
ization by different vessels coming off of the descending aorta: the
foregut is vascularized by the celiac trunk, the midgut by the su-
perior mesenteric artery, and the hindgut by the inferior mesen-
teric artery (Sadler, 2012). The foregut will give rise to the oral
cavity, pharynx, esophagus, respiratory tract (proximal conducting
airways and distal alveolar tissue), stomach, liver, pancreas, and
proximal duodenum. The midgut and hindgut give rise to the restInc. This is an open access article u
l Medicine, Division of Gas-
Ann Arbor, MI, United States.of the small intestine (distal duodenum, jejunum, and ileum) as
well as the colon, and the common cloaca (Grapin-Botton, 2005;
Zorn and Wells, 2009). The cloaca will be separated by the uror-
ectal septum to form the rectum and anal canal on the dorsal
portion of the embryo and the urogenital sinus on the ventral
portion (Grapin-Botton, 2005; Seifert et al., 2009a, 2008, 2009b;
Zorn and Wells, 2009). The endoderm of the urogenital sinus will
give rise to the epithelial lining of the bladder and urethra (Seifert
et al., 2008; Zorn and Wells, 2009). With so many critically timed
morphological and functional changes, this delicate orchestration
leaves the developing embryo vulnerable to a plethora of con-
genital anomalies and disease processes.
For the past several decades, our understanding surrounding
normal and abnormal human development has been limited to the
use of rare human samples, and inferences from studies using
animal models. Interestingly, there is signiﬁcant interspecies var-
iation in the context of the respiratory and digestive systems de-
velopment. For instance, the postnatal mouse intestine continues
to develop for two weeks after birth before the crypt domains are
properly formed, and before Paneth cells differentiate (Kim et al.,
2012). In contrast, human studies have indicated that crypts and
Paneth cells are present by the third trimester of gestation (Heida
et al., 2016). Similarly, there are intrinsic differences between
humans and mice within lung tissue as well. Basal cells, which arender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Directed Differentiation of hPSCs to a Lung and Intestinal Organoid FatehPSC
with the use of ActivinA can be differentiated into predominantly endoderm (in
yellow) with some proportion of cells adopting a mesoderm fate (in red). When
exposed to foregut (Noggin, small molecule TGFB inhibitor) or hindgut (WNT3A,
FGF4) speciﬁc growth factors the endoderm is patterned accordingly. WNT3A and
FGF4 appear to be critical for 3-dimensionality and spheroid formation, so that
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throughout the human conducting airways but are conﬁned to the
trachea of mice (Boers et al., 1998; Nakajima et al., 1998). Human
airways also contain goblet cells, which are less common in rodent
airways (Rock et al., 2010). Despite some limitations that come
with cell lines and animal models, there is no doubt that our un-
derstanding of the cellular and molecular basis of organ devel-
opment has been substantially advanced by model organism re-
search. Therefore, our recent ability to couple model organism
research with complex, organ-like in vitro human models (orga-
noids) provides new opportunities to understand diseases that
present important challenges in the clinical setting today (St
Johnston, 2015).
Organoids are complex multi-cellular structures that exhibit
some of the structural and functional features of the native organ.
These tissues fall under two broad categories: organoids that are
obtained de novo through the differentiation of human pluripotent
stem cells (hPSCs), and those that are derived from a native tissue
source, for example, from a tissue biopsy of an individual (Dedhia
et al., 2016). hPSC-derived and tissue-derived culture systems for
both lung and intestinal organoids have been have been ex-
tensively reviewed recently (Dedhia et al., 2016; Dye et al., 2016;
Fatehullah et al., 2016; Nadkarni et al., 2015). Therefore, we will
brieﬂy discuss the work that has contributed to our ability to
differentiate hPSCs into lung and intestinal organoid tissues,
however; this review will be primarily focused on highlighting
important clinical challenges that affect the lungs and intestines of
neonates for which hPSC-based systems may be used to shed new
light on poorly understood disease processes.when added to foregut speciﬁc growth factors, foregut spheroids are formed.
Spheroids collected and placed in Matrigel droplets are allowed to grow in three
dimensions into organoid tissue. These organoids are maintained and passaged in
tissue speciﬁc growth factors (lung: SAG and FGF10) (Intestinal: EGF, Noggin,
R-Spondin [ENR]) for up to a year.2. hPSC derived lung and intestinal organoids: models of im-
mature human tissues
Human pluripotent stem cells are human cells with the ability
to differentiate into any cell type in the human body. They include
human embryonic stem cells (hESCs) (Thomson et al., 1998) as
well as induced pluripotent stem cells (iPSCs), which are somatic
cells reverted to a pluripotent state through cellular reprogram-
ming (Takahashi et al., 2007; Takahashi and Yamanaka, 2006).
Seminal work in this area has led to the emergence of a whole ﬁeld
focused on understanding how human pluripotent stem cells can
be used to better understand human development and disease ‘in
a dish’ (St Johnston, 2015). In general, the ﬁeld has adopted an
approach known as directed differentiation. This approach uses
information gained from decades of animal model research to coax
cells into different lineages through a step-wise process that at-
tempts to mimic gastrulation, patterning and lineage commitment
(Turner et al., 2016). Early work in this area made major con-
tributions to our ability to generate endoderm lineages, as well as
pancreatic beta-like cells, and liver hepatocyte-like cells (D’Amour
et al., 2006; Kroon et al., 2008; Si-Tayeb et al., 2010).
More recently, many groups have achieved differentiation of
complex 3-dimensional organ-like structures from hPSCs, includ-
ing intestine, stomach, lung, kidney, brain and retina among others
(D’Amour et al., 2006; Dye et al., 2015; Kroon et al., 2008; Lan-
caster et al., 2013; McCracken et al., 2014; Nakano et al., 2012; Si-
Tayeb et al., 2010; Takasato et al., 2015; Wells and Spence, 2014).
As the epithelial lining of the intestine and lung are both derived
from the endodermal germ layer, successful differentiation of in-
testine and lung organoid tissues in vitro begins by directing
pluripotent stem cells into the endodermal lineage by stimulating
Transforming Growth Factor Beta (TGF-beta) signaling using Ac-
tivinA, which mimics the Nodal signaling that is critical for me-
sendoderm speciﬁcation in the embryo (D’Amour et al., 2005).
Following gastrulation in vivo and in vitro, the endoderm isstructured as a monolayer of epithelial cells. In the embryo, this
sheet of cells is patterned along the rostral-caudal axis into the
foregut, midgut and hindgut. In vivo signaling pathways thought to
be important in rostral/foregut endoderm patterning include No-
dal inhibitors (Lefty1 and Cerberus-like) and Bone Morphogenic
Protein (BMP) inhibitors (Chordin and Noggin), which act to in-
hibit posterior patterning (Perea-Gomez et al., 2002; Tiso et al.,
2002; Yamamoto et al., 2004). Signaling pathways important in
caudal/hindgut endoderm patterning in vivo include Fibroblast
Growth Factors (FGFs), Retinoic Acid (RA), WNT, and BMP (Wang
et al., 2006). In vitro, addition of WNT3A and FGF4 to the deﬁnitive
endoderm (DE) monolayer causes cells to adopt a caudal/hindgut
fate and to form small aggregates called spheroids that detach and
ﬂoat above the adherent monolayer (Fig. 1). These spheroids can
be placed in an extracellular matrix such as Matrigel where they
continue to expand and grow in three dimensions, giving rise to
larger organ-like structures called intestinal organoids (Spence
et al., 2011; Wells and Spence, 2014). Expansion and growth of
intestinal organoids required several growth factors that were
shown to be critical for long term ex vivo growth of tissue-derived
intestinal crypts (Ootani et al., 2009; Sato et al., 2009). For rostral/
foregut speciﬁcation in vitro, hPSC derived DE can be patterned
into foregut by inhibiting BMP/TGFβ signaling using Noggin (NOG)
and/or small molecule inhibitors (Fig. 1) (Green et al., 2011; Han-
nan et al., 2013; 2015; McCracken et al., 2014).
Concomitant stimulation of DE cultures with spheroid-indu-
cing factors (WNT3A/FGF4) and foregut pattering factors (NOG/
TGFβ-inhibitors) led to the formation of foregut spheroids, which
expand into larger lung-organoid structures. As with intestinal
organoids, expansion of hPSC-derived lung organoids was guided
by information from animal development and from work
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et al., 2014; Rock et al., 2009). The ability of hPSC-derived tissues
to self assemble in vitro is a remarkable, but poorly understood
process, especially given that growth factor gradients thought to
be critical for tissue organization in the developing embryo are
often lacking from in vitro systems (Turner et al., 2016). While
more work is needed to understand the self-assembly of tissues in
vitro, it has been suggested that spheroid/organoid formation is
not due to an intrinsic ability of tissues to “self-organize”, rather de
novo formation of these structures is the result of initiating genetic
programs that lead to self-assembly of structures in vitro that re-
semble in vivo structures following morphogenesis (Turner et al.,
2016). The notion that organoids form by initiating a complex
genetic program that ultimately leads to self-assembling struc-
tures is an intriguing idea given the observation that directed
differentiation of hPSCs into endoderm is an inefﬁcient process,
leading to the differentiation of both endoderm and non-en-
dodermal derivatives, including mesoderm (Fig. 1) (Spence et al.,
2011). While not yet experimentally tested, it is possible that cell-
cell interactions and cell-cell signaling resulting from ‘inefﬁcient’
differentiation may be important for recapitulating aspects of the
developmental programs required for formation 3-dimensional
structures. Indeed, intestine, lung and gastric organoids derived
from hPSCs all contain epithelium and supporting mesenchyme in
a three-dimensional structure reminiscent of the developing hu-
man fetus (Dye et al., 2015; Finkbeiner et al., 2015b; McCracken
et al., 2014; Spence et al., 2011; Watson et al., 2014).
In many cases, lung and intestinal organoids share several
properties: they can be maintained in culture for several months
and they possess a complex and diverse epithelium as well as
supporting mesenchymal tissue, although it should be noted that
mesenchyme free systems also exist (Fordham et al., 2013; Gotoh
et al., 2014; Hannan et al., 2013; Konishi et al., 2016). Human lung
organoid (HLO) epithelium includes basal cells and ciliated cells, as
well as diverse mesenchymal cells (myoﬁbroblasts, ﬁbroblasts, and
smooth muscle cells) that can be found in both proximal con-
ducting airway-like structures as well as areas that possess al-
veolar cell types (Fig. 2) (Dye et al., 2015). Human intestinal or-
ganoids (HIOs) also include many functionally distinct cell types
including epithelial cells (enterocytes, enteroendocrine cells,Alv
Lung Organoid
Fig. 2. Alveolar like Tissue in Lung Organoids contains Alveoli type 1 and 2 Pneumocytes
as alveolar type 1 and 2 pneumocytes (AECI and AECII cells) surrounded by ﬁbroblasts.
cells. These AECII cells contain lamellar bodies, which are responsible for manufacturingoblet cells, and Paneth cells) and mesenchymal cells (myoﬁbro-
blasts, ﬁbroblasts, and smooth muscle cells) which are organized
into cyst-like structures with a columnar epithelium-lined lumen
with supporting mesenchyme found adjacent to the basal surface
of the epithelium (Spence et al., 2011; Wells and Spence, 2014).
Interestingly, a common feature of many hPSC-derived cells,
tissues and organoids in many cases, is that they remain in a
transcriptional and functional state that is similar to fetal human
tissue (Dye et al., 2015; Finkbeiner et al., 2015b; Fordham et al.,
2013; Hannan et al., 2013; Hrvatin et al., 2014; Si-Tayeb et al., 2010;
Takasato et al., 2015). It is currently unclear why organoid models
fail to ‘mature’ in vitro, and further work is required to better
understand this phenomenon. A common method in the ﬁeld to
further mature hPSC-derived tissues, including organoids, is to
transplant in vitro derived tissues into immunocompromised mice
(Finkbeiner et al., 2015b, 2015a; Watson et al., 2014). In many
cases, this has led to remarkable morphological and functional
maturation into an adult-like state. For example, when intestinal
organoids are placed under the renal capsule, they become vas-
cularized by the host, can ﬂourish for many months, and are re-
modeled such that the simple epithelium seen in vitro gives rise to
crypt and villus-like structures that closely resemble the sophis-
ticated organization of the mature intestine. This includes deep
crypts that possess Paneth cells and cells expressing the intestinal
stem cell markers LGR5 and OLFM4 as well as longer and more
mature villi that express brush border enzymes and other markers
of mature small intestine such as dipeptidyl peptidase 4, glucose
transporter type 2, and villin (Finkbeiner et al., 2015b, 2015a;
Watson et al., 2014). Thus, hPSC-derived tissues that are fetal/
immature in vitro appear to become morphologically and func-
tionally similar to the mature adult epithelium when transplanted
in vivo. Consistent with the concept of in vivo maturation, in-
testinal tissue generated by transplanting undifferentiated hPSCs
into mice in order to form teratomas proved to be similar to the
mature adult intestine. Intestinal organoids generated from ter-
atoma-derived tissue, having come from an in vivo environment,
yielded more mature adult like gene expression and behavior
(Forster et al., 2014). It is important to note, however; that despite
the strong similarities between organoids and fetal tissue, and
transplanted organoids and adult tissue, many comparisonsAlveolar Type II
Alveolar Type I
Fibroblast
eolar-like Epithelium Surrounding Tissue
Lamellar Body
Alveloar Type II cell
and Lamellar Bodies. Lung organoids contain cell types associated with alveoli such
AECII cells are more rounded in shape and found located between elongated AECI
g surfactant proteins both in the lung organoids and in vivo human lung tissue.
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cells. For example, intestinal organoids have been compared to
whole thickness fetal intestine (Finkbeiner et al., 2015b). Thus,
while similarities between tissues exist, how similar speciﬁc tissue
compartments are (i.e. epithelium vs. epithelium) or how similar
individual cell types are between in vitro-derived and organ-de-
rived tissues is currently unknown. In this light, systems where
hPSCs have been differentiated into epithelium-only organoids
(Fordham et al., 2013; Hannan et al., 2013) can be leveraged in
order to more fairly compare differences with the human fetal
epithelium (Fordham et al., 2013).
The immature/fetal nature of these hPSC-derived in vitro
models makes them the only non-primary human fetal model
system to suitable for exploring the immature lung or intestine.
Therefore, these organoid models are uniquely poised to model
diseases of the immature human neonate. In the same vein, due to
similarities with the adult intestine, transplanted hPSC-derived
organoids are more appropriate for modeling mature/adult tissue.
Importantly, our understanding of human development to aid
premature infants born with immature intestine and lungs is
particularly limited. This is unfortunate for patients in the neonatal
intensive care unit, who experience a delay, derailment, or arrest
in development at these stages. The remainder of this review will
focus on clinical challenges for which immature/fetal organoids
present important new avenues for furthering our understanding
of human development and disease.3. The premature lung: potential applications for HLOs
Prematurity (infants born at less than 37 weeks gestation) is a
signiﬁcant problem in both the developed and developing world.
Preterm births in the United States accounted for 11.39% of all
births in 2013 (Martin et al., 2015). We are fortunate that care of
the premature infant has made incredible strides in the past sev-
eral decades. It is well-established that the current margin of
viability is 23–24 weeks of gestation, though there is ongoing
debate prompting consideration of the viability of 22 week fetuses
as well (Rysavy et al., 2015). Compare this to 1963 when President
John F. Kennedy's premature son died of immature lung devel-
opment at the gestational age of 34 weeks.
Major advances in neonatal care can be largely attributed to
two major breakthroughs, both involving the immature re-
spiratory system of the preterm. First, since alveolar type II cells
(AECII) in the immature lung does not generate sufﬁcient surfac-
tant protein, the commercial availability of surfactant in the 1990s
allowed for the delivery of this surface tension relieving choline
based phospholipid directly to the lungs via an endotracheal tube
(Suresh and Soll, 2005). With surface tension relieved, compliance
of the immature lung was signiﬁcantly improved so that me-
chanical ventilation could be more effective and less likely to cause
detrimental damage to alveoli via high pressure and air leaks.
Pulmonary surfactant was ﬁrst discovered in the 1950s and was
later described as the key player in “hyaline membrane disease”
now known as “respiratory distress syndrome of the premature
infant” or RDS (Notter and Shapiro, 1981).
Several transcription factors, lipid modiﬁers, and signaling
pathways (i.e. BMP, NKX2-1, and Nfatc3) have been described as
important in the production of surfactant and its associated pro-
teins (DeFelice et al., 2003; Ikegami et al., 2000; Luo et al., 2016;
Whitsett and Weaver, 2015; Whitsett et al., 2010), however; we
still know relatively little about maturation of alveolar cell types.
Since there is evidence that human lung organoids possess al-
veolar type I cells (AECI) and AECII, it is possible that this model
system may be beneﬁcial to understand how alveolar cell types
mature. Additionally, infants with mutations in genes speciﬁc tosurfactant and its associated proteins (SFTPB, SFTPC, ABCA3) are
rare and often left unidentiﬁed until late in presentation until all
other more common conditions have been excluded (Wert et al.,
2009). Sftpb / in particular is a fatal condition not responsive to
ventilator management or surfactant replacement therapy (Clark
et al., 1995) and lung organoids offer an opportunity to model
these types of lethal mutations.
Premature infants not only suffer from surfactant deﬁciency
ameliorated by surfactant replacement therapy, but also from an
arrest in alveolar maturation. Alveoli in the preterm lungs are
lacking in both quantity as well as quality. Alveoli present in
preterm lungs, especially those prior to 28 weeks gestation are still
in the saccular phase of lung development (for reviews on lung
development, see: Herriges and Morrisey, 2014; Morrisey et al.,
2013; Morrisey and Hogan, 2010. ). These alveoli have thick walls
with blood vessels located far from the minimal airspaces that are
required for gas exchange (Rodriguez, 2002). Despite the avail-
ability of surfactant therapy, this ventilation-perfusion mismatch
poses a signiﬁcant problem for neonatologists managing ex-
tremely low gestation age infants on mechanical ventilators
(Whitsett and Weaver, 2015). Mechanical ventilation, inﬂamma-
tion associated with preterm birth and its sequelae, and arrested
pulmonary development are all likely contributors to the long
term chronic condition described as bronchopulmonary dysplasia
or BPD (Northway et al., 1967). The estimated economic and social
costs of managing preterm infants with BPD are not limited to
their stay in the neonatal intensive care unit. After discharge, in-
fants with BPD are often managed on home oxygen or home
ventilators with several pulmonary medications and frequent
hospitalizations. They are more likely to be hospitalized for re-
spiratory conditions such as viral infections, cardiovascular dis-
ease, and asthma (Bolton et al., 2012; Saarenpää et al., 2015).
Therefore much interest has been focused on inducing lung ma-
turation in extremely low gestation age infants with the hopes of
avoiding some of these chronic complications.
Seminal animal model research in the late 1960s led to the
discovery that steroid administration hastened lung development
in preterm animals (Avery, 1995). This observation led to small
clinical trials in human mothers at risk for preterm delivery (Avery,
1995). Promising results inspired a much larger randomized con-
trol trial sponsored by the National Heart Lung and Blood Institute
of a maternally administered transplacentally circulating gluco-
corticoid, dexamethasone. At a conference held by the NIH, ma-
ternal steroid administration for the maturation of fetal lung de-
velopment was made the new standard of care, effectively redu-
cing neonatal mortality by 40% (Avery, 1995). With these guide-
lines, neonatologists have seen a sharp decline in the amount of
RDS and BPD within each gestational age bracket. However, this
also led to the ability to resuscitate babies born at younger and
younger gestational ages and RDS and BPD are still quite prevalent
in neonatal intensive care units around the globe.
Despite the fact that corticosteroid administration to at-risk
mothers enhances fetal lung maturation and has dramatically re-
duced mortality rates, the mechanism of maturation is largely
unclear. There is some evidence that steroid administration ac-
celerates AECI and AECII pneumocyte development (Bonanno and
Wapner, 2009). Surfactant production is potentially accelerated by
induction of the surfactant proteins and enzymes necessary for
phospholipid synthesis (Ballard and Ballard, 1995). Antenatal
steroids also induce pulmonary beta-receptors, which play a role
in surfactant release and absorption of alveolar ﬂuid (Ballard and
Ballard, 1995). By this mechanism, induction of fetal lung anti-
oxidant enzymes and the upregulation of the epithelial Naþ
channels enhance absorption of fetal lung ﬂuid after birth
(O’Brodovich, 1996). In tissue culture experiments, these bio-
chemical changes and surfactant effects appear to be temporary,
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rhesus monkey models (Ballard and Ballard, 1995; Bonanno and
Wapner, 2009; Bunton and Plopper, 1984). With this rationale,
antenatal steroid (usually dexamethasone or betamethasone) may
be repeated in pregnant women still at risk for delivery every 2–4
weeks as the exact date of delivery is often difﬁcult to predict.
hPSC derived human lung organoids are relatively new on the
scene and have yet to be used to model patient disease. However,
given a high degree of similarity to the human fetal lung, they offer
novel opportunities to investigate mechanisms of lung maturation,
such as antenatal corticosteroid administration. Although this
therapy is already widely used clinically, a better understanding of
how this therapy affects the immature lung may lead to better or
alternative treatments that may not carry the negative side effects
associated with “big-gun” steroid delivery. Many experts in the
ﬁeld remain concerned about administering multiple repeat
courses of steroid therapy (Crowther et al., 2015; Waffarn and
Davis, 2012), citing trials suggesting that increased exposure to
steroids is associated with increasing risk of adverse effects such
as growth difﬁculty and poor neurologic outcomes (such as cere-
bral palsy) (Waffarn and Davis, 2012).
Pulmonary hypoplasia is a condition that can be the result of
several congenital syndromes such as congenital diaphragmatic
hernia (CDH) where abdominal contents are displaced into the
chest, inhibiting lung formation (Langer, 1998). Pulmonary hypo-
plasia can also be a result of oligo- or anhydramnios (absence of
amniotic ﬂuid) due to either premature rupture of membranes or
an obstructive uropathy such as posterior urethral valves (PUV)
(Zingg-Schenk et al., 2008). In some situations such as congenital
pulmonary airway malformations (CPAMs), large cystic structures
within the thorax prevent adequate lung tissue from forming
(Marchiori et al., 2015). These neonates are not only born lacking
sufﬁcient lung tissue, but many of them are born premature as
well, often adding RDS and/or BPD to their list of complications.
These infants would greatly beneﬁt from tissue regenerative ef-
forts. HLOs would offer signiﬁcant advantages over traditional and
rarely available or successful neonatal lung transplants. Diagnoses
of these congenital conditions are often made prenatally, months
before birth or need for a respiratory organ other than the pla-
centa. This potentially leaves months of time to generate iPSCs and
pulmonary tissue speciﬁc to the patient, essentially eliminating
the need for harmful immunosuppressive medications. Currently,
some groups have made progress in engineering lung tissue using
iPSCs seeded onto de-cellularized human and rodent cadaver lung
matrices (Charest et al., 2015; Ghaedi et al., 2013; Gilpin et al.,
2014a, 2014b; Gilpin and Ott, 2015; Ren et al., 2015). Many of these
models show promise in that they appear to have a differentiated
pulmonary epithelium and are able to exchange gas for short
periods of time. While this area still has far to go before applicable
to premature infants, it is non-the-less an exciting area of
investigation.4. The premature intestine: potential applications for HIOs
Prenatally, the placenta is the organ not only of respiration but
of nutrient delivery as well. In the preterm population, the last
trimester is cut short, preventing full accretion of many critical
nutrients including vitamins and minerals such as iron, calcium,
and phosphorous (Hay et al., 1999). Current medical management
of preterm infants usually includes total parenteral nutrition
(TPN), often delivered through the use of a central venous catheter.
This method of nutrition poses multiple problems, most notably
the risk of complications from central venous catheters such as
infection, as well as inadequate nutrient delivery due to TPN's
inability to fully mimic the placenta (Cronin et al., 1990). Adequatecalorie delivery is often limited by ﬂuid volume tolerance due to
edema, bronchopulmonary dysplasia, and persistent fetal vascular
circulation. Additionally, many extremely low birthweight (ELBW)
premature infants do not tolerate high dextrose infusion rates due
to an immature insulin response. Long-term total parenteral nu-
trition is associated with signiﬁcant cholestasis leading to a direct
hyperbilirubinemia and liver damage (Lacaille et al., 2015). Lastly,
TPN alone is unable to provide sufﬁcient calcium and phosphorus
alimentation due to precipitation of these solutes in solution. This
puts preterm infants at risk for osteopenia, rickets, and bone
fractures (Koo, 1992). For these reasons, among others, goals set by
neonatal caregivers to mimic the same growth that might have
been achievable with the help of the placenta are simply not ob-
tainable. Not only is TPN signiﬁcantly limited in its ability to
provide complete nutrients needed for adequate growth, but also
there is a growing body of literature suggestive that it may actually
be harmful to the developing gut. For example, TPN has been
implicated in mucosal atrophy and the loss of epithelial barrier
function (Feng et al., 2009).
The limitations and risks associated with the use of TPN have
lead caregivers to aim for full enteral feeds as quickly as the
neonate's immature gastrointestinal tract is able to tolerate, which
can ultimately lead to necrotizing enterocolitis (NEC), a serious
complication that can affect the immature intestine. In its early
stages NEC can mimic the signs and symptoms of feed intolerance.
NEC is the most common gastrointestinal emergency in the
newborn, affecting about 7% of preterm infants (Neu, 1996). The
smallest of these infants (o750 g) have the highest morbidity
(12%) and mortality (42%) from the disease. About 90% of NEC
occurs in premature infants, suggesting prematurity as a key factor
in the disease process (Neu, 1996). NEC is most often described as
the “ischemic necrosis of the intestinal mucosa, which is asso-
ciated with inﬂammation, invasion of enteric gas forming organ-
isms, and dissection of gas into the muscularis and portal venous
systems” (Fitzgibbons et al., 2009; Neu, 1996). Perhaps the most
frustrating aspect of this illness is its unpredictable nature, af-
fecting neonates at a time when they seem otherwise healthy
(Kliegman et al., 1993). The average time of onset of disease is
between 3 and 5 weeks of life, usually after the patient has
reached relative stability in their hospital course (Uauy et al.,
1991). The ﬁrst clinical signs of NEC are very similar to feed in-
tolerance: vomiting, abdominal distention and tenderness, and
gastric residual ﬂuid. Additionally, patients can develop bloody
stools and other systemic signs of illness such as temperature in-
stability, increased need for respiratory support, shock, and in the
most severe cases, death (Neu and Walker, 2011). Dissection of gas
into the bowel wall called “pneumatosis intestinalis” can some-
times be seen on plain radiograph, and to some degree ultra-
sonography. About 30% of patients will develop culture proven
bacteremia (Lin and Stoll, 2006). Inﬂamed bowel has a propensity
to perforate, leading to pneumoperitoneum. Necrotizing en-
terocolitis totalis is when the entire gut has been affected leaving
no residual live bowel, a condition incompatible with life.
Unfortunately, the pathophysiology surrounding NEC has re-
mained unclear and progress over the past several decades in re-
ducing NEC incidence or severity has been modest at best. One
prominent theory of NEC vulnerability suggests that defenses
against invasive microbes are impaired leading to increased in-
ﬂammation within the immature gut. HIOs could be a useful tool
in delineating how luminal pH, Paneth cell activity, mucous pro-
duction, and gap junctions not only mature, but how they interact
with environmental exposures (bacteria, food products) and po-
tential therapeutic interventions (Ford, 2006; Lin and Stoll, 2006;
Neu, 1996). Gap junctions in particular have been of great interest
to NEC researchers, as permeability of the mucosal barrier seems
to be a key variable in the triggering an inﬂammatory cascade in
Time
Time
Intact Epithelial Barrier
Damaged Epithelial Barrier
Microinjection with Dye 
(FITC-dextran)
HIOs in Matrigel
(Bright-Field)
(Bright-Field)
(GFP Channel) (GFP Channel)
(GFP Channel) (GFP Channel)
Fig. 3. HIO Barrier Function Assay using FITC-dextran Dye Microinjection. Cystic HIOs are placed in Matrigel droplets to secure them in place. Glass pulled microinjection
pipettes are ﬁlled with FITC-dextran dye and carefully inserted into the cystic organoid without causing signiﬁcant disturbance to the epithelium. Experimental conditions
could include adding treatments, insults, or microbes to the media or the intraluminal compartment through microinjection. Intact epithelial barrier will result in dye
retention over time, while a damaged epithelium will result in dye leakage and decreased luminescence over time.
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matures intestinal barrier function, which is the proposed me-
chanism by which it reduces NEC incidence (Halac et al., 1990).
However, much like antenatal steroid induced maturation of the
premature lung, the exact mechanism as to how glucocorticoids
are maturing or strengthening the epithelial barrier is unclear and
needs further investigation. HIOs contain a luminal component
lined with immature epithelium. This organization and structure
has allowed researchers to study the epithelial barrier by injecting
dye such as FITC-dextran into the lumen of the organoid and
tracking epithelial leak over time by measuring loss of luminal
ﬂuorescence (Fig. 3) (Leslie et al., 2015). The same study demon-
strated that intestinal organoids could be used to model changes
in epithelial barrier function in response to exposure from differ-
ent environmental stimuli such as bacterial toxins and calcium
chelators (Fig. 3) (Leslie et al., 2015). Functional studies of the HIO
epithelial barrier assays could be extended to further delineate the
mechanisms leading to perturbed function, such as nutrient deﬁ-
cits, during TPN delivery (Feng et al., 2009).
The development of the intestinal microbiota also seems to be
an important factor in NEC pathogenesis. Bacterial colonization is
necessary for NEC development, as NEC does not occur in utero
when the gut is sterile, nor are standardized experimental proto-
cols able to produce NEC in germ free animals (Lin and Stoll, 2006;
Morowitz et al., 2010; Patel and Denning, 2015). In the premature
infant, a number of factors including virulent nosocomial patho-
gen exposure, prolonged antibiotic delivery, poor peristaltic mo-
tility, and the absence of human milk feedings can lead to dis-
ruption of the host microbial community (AlFaleh and Anabrees,
2014; Hunter et al., 2008; Lin and Stoll, 2006; Morowitz et al.,
2010; Patel and Denning, 2015; Stewart et al., 2012). Bacteria in-
teract with the host through toll like receptors (such as TLR2 and
TLR4) to regulate gene expression through inﬂammatory media-
tors such as NF-κB (Chan et al., 2014; Lin and Stoll, 2006). Bacteria
likely play a role in NEC by inducing intestinal inﬂammation and
apoptosis through bacterial components such as lipopolysacchar-
ide (LPS). Probiotics, which theoretically add to the pool of com-
mensal bacteria in the host microbial community, have been
shown in several clinical randomized controlled trials as well as a
Cochrane Systematic Review in 2014 to signiﬁcantly reduce theincidence of NEC amongst premature infants (AlFaleh and Ana-
brees, 2014). Routine administration of probiotics is not yet re-
commended, nor has it become the standard of therapy for NEC
prevention due to concerns about the safety and lack of FDA reg-
ulation of a biologic agent given to functionally immune-com-
promised premature patients.
HIOs offer an opportunity to study host-microbe interactions in
a way that has previously not been possible (Leslie and Young,
2016). A number of groups have used the microenvironment of the
organoid lumen to culture bacteria such as Helicobacter pylori,
Salmonella, and Clostridium difﬁcile (Bartfeld et al., 2015; Forbester
et al., 2015; Leslie et al., 2015; Schumacher et al., 2015). These
bacteria grow, proliferate and effect host gene expression and
epithelial function within the organoid. Organisms thought to be
important in NEC pathogenesis and prevention, both pathogenic
and commensal, could also theoretically also be introduced within
the host HIO lumen as a model of the immature gut to study in-
ﬂuence on gene expression, mucus production and other histolo-
gical changes, as well as functional permeability of the epithelial
barrier.
Lastly, infants born with congenital bowel malformations such
as gastroschisis, omphalocele, congenital diaphragmatic hernia, or
those who require large segments of bowel resection due to NEC,
intestinal atresia, or spontaneous intestinal perforation could
greatly beneﬁt from PSC derived regenerative therapies in the
future. Without sufﬁcient surface area for nutrient absorption,
many children suffer from chronic malnutrition and TPN depen-
dence. They accrue the risks associated with long-term central
venous access for TPN delivery (Wessel and Kocoshis, 2007). Long-
term central venous access can lead to severe infections and even
death. In addition to calorie malabsorption, many children are
missing critical portions of the bowel responsible for vitamin and
mineral acquisition. For example, neonates and children with ileal
resections are predisposed to vitamin B12 (pernicious anemia) and
bile acid (necessary for fat soluble vitamins A,D,E, and K absorp-
tion) deﬁciencies (Wessel and Kocoshis, 2007). To date, intestinal
organoids, while effectively engrafting in the mouse kidney, have
not been used to lengthen existing bowel (Finkbeiner et al., 2015a;
Watson et al., 2014). Adult tissue-derived epithelial organoids,
when introduced via enema to mice with DSS induced colitis,
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These mice also showed better weight gain at 2 weeks than mice
that did not receive enemas containing tissue-derived intestinal
organoids, suggesting that engrafting in vitro grown tissue into the
native intestine is a possibility (Yui et al., 2012). Some studies have
used ‘organoid units’ which are derived from minced mature or
neonatal whole thickness intestinal fragments (Choi and Vacanti,
1997; Grant et al., 2015). These researchers were able to create
tissue-engineered small intestine (TESI) after placing these units
on scaffolds and transplanting them into mice. Placement of TESI
in a re-anastomosed section of bowel successfully lengthened the
small intestine 9 months later (Kaihara et al., 2000). However,
TESIs cannot currently be expanded in vitro. hPSC derived in-
testinal organoids may hold more promise in lengthening tech-
niques due to their self assembly with a signiﬁcant outer me-
senchymal component (Barthel et al., 2012; Finkbeiner et al.,
2015a; Grant et al., 2015; Grant and Grikscheit, 2013; Levin et al.,
2013). However, in contrast to adult tissue, signiﬁcant plasticity
has been demonstrated in transplanted fetal mouse intestine,
suggesting that transplanted tissue loses its regional identity and
can take on the characteristics of the region-speciﬁc site of
transplantation (Fordham et al., 2013; Fukuda et al., 2014). With
this caveat in mind, use of hPSC-derived organoids for tissue re-
placement therapy could present problems for infants who may
have lost whole segments of bowel (such as the ileum), in which
case transplanted tissue may take on characteristics of nearby
tissue (such as the jejunum) rather than the desired absent tissue
(ileum).5. Future directions
hPSC-derived tissues generated through directed differentia-
tion are inherently immature in nature and therefore make ex-
cellent models to study of diseases of the immature and premature
human. Both respiratory and digestive systems of the premature
infant are in great need of further investigation using human
model systems such as hPSC derived human lung and intestinal
organoids. We hope that highlighted areas of importance for
premature neonates within this review sparks inspiration, co-
operation, and innovation amongst the basic science and neonatal
research communities to come together to assist this vulnerable
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